Intensive Care Medicine

, Volume 31, Issue 3, pp 408–415 | Cite as

Impact of two different comorbidity measures on the 6-month mortality of critically ill cancer patients

  • Márcio Soares
  • Jorge I. F. Salluh
  • Carlos Gil Ferreira
  • Ronir R. Luiz
  • Nelson Spector
  • José R. Rocco
Original

Abstract

Objective

To evaluate the impact of two different comorbidity measures on the 6-month mortality of severely ill cancer patients.

Design and setting

Prospective cohort study in a ten-bed oncological medical-surgical intensive care unit (ICU).

Patients

A total of 772 consecutive patients were included over a 45-month period. The mean age was 57.6±16.4 years, and 642 (83%) patients had solid tumors.

Measurements and results

Data were collected on admission and during ICU stay. Comorbidities were evaluated using the Charlson Comorbidity Index (CCI) and the Adult Comorbidity Evaluation (ACE-27). The ICU, hospital, and 6-month mortality rates were 34%, 47%, and 58%, respectively. The most frequent comorbidities were hypertension (33%), diabetes mellitus (8%), and chronic pulmonary disease (7%). There were important differences between the two indices regarding the comorbidity evaluation. Using the ACE-27, 389 patients (50%) had comorbid ailments that were classified as mild (31%), moderate (14%), and severe (5%) according to the comorbidity severity. According to the CCI, 212 patients (27%) had a comorbidity, and their median score was 1 (1–2). In the multivariable Cox proportional hazard models only the presence of a severe comorbidity by the ACE-27 was associated with increased mortality. The CCI was not independently associated with the outcome. Other outcome predictors were older age, poor performance status, active cancer, need of mechanical ventilation, and severity of acute organ failures.

Conclusions

Severe comorbidities must be considered in the outcome evaluation of ICU cancer patients. The ACE-27 seems to be a useful instrument for prognostic assessment in this population.

Keywords

Cancer Comorbidity Intensive care Mortality Survival analysis Outcome 

References

  1. 1.
    Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519–525CrossRefPubMedGoogle Scholar
  2. 2.
    Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le Gall JR, Schlemmer B (2000) Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 26:1817–1823CrossRefPubMedGoogle Scholar
  3. 3.
    Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 31:104–112CrossRefPubMedGoogle Scholar
  4. 4.
    Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB (1999) Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 160:1957–1961PubMedGoogle Scholar
  5. 5.
    Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328CrossRefPubMedGoogle Scholar
  6. 6.
    Groeger JS, Lemeshow S, Price K, Nierman DM, White P Jr, Klar J, Granovsky S, Horak D, Kish SK (1998) Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16:761–770PubMedGoogle Scholar
  7. 7.
    Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRefPubMedGoogle Scholar
  8. 8.
    Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441–2447CrossRefGoogle Scholar
  9. 9.
    Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF (2004) Differential prognostic impact of comorbidity. J Clin Oncol 22:3099–3103CrossRefGoogle Scholar
  10. 10.
    Yancik R, Ganz PA, Varricchio CG, Conley B (2001) Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 19:1147–1151PubMedGoogle Scholar
  11. 11.
    Groeger JS, White P Jr, Nierman DM, Glassman J, Shi W, Horak D, Price K (1999) Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 17:991–997Google Scholar
  12. 12.
    Soares M, Fontes F, Dantas J, Gadelha D, Cariello P, Nardes F, Amorim C, Toscano L, Rocco JR (2004) Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: A prospective observational study. Crit Care 8:R194–R203CrossRefGoogle Scholar
  13. 13.
    Le Gall J-R, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedGoogle Scholar
  14. 14.
    Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMedGoogle Scholar
  15. 15.
    Zubrod CG, Schneiderman M, Frei III E, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones Jr R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens Jr AH (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11:7–33CrossRefGoogle Scholar
  16. 16.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedGoogle Scholar
  17. 17.
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140PubMedGoogle Scholar
  18. 18.
    Johnston AS, Piccirillo JF, Creech C, Littenberg B, Jeffe D, Spitznagel EL (2001) Validation of a comorbidity education program. J Registry Manage 28:125–131Google Scholar
  19. 19.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMedGoogle Scholar
  20. 20.
    Kleinbaum DG (1996) Survival analysis: a self-learning text. Springer, Berlin Heidelberg New YorkGoogle Scholar
  21. 21.
    Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481Google Scholar
  22. 22.
    Schellongowski P, Benesch M, Lang T, Traunmuller F, Zauner C, Laczika K, Locker GJ, Frass M, Staudinger T (2004) Comparison of three severity scores for critically ill cancer patients. Intensive Care Med 30:430–436CrossRefGoogle Scholar
  23. 23.
    Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A (1993) Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 269:783–786CrossRefGoogle Scholar
  24. 24.
    Sculier JP, Paesmans M, Markiewicz E, Berghmans T (2000) Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med 28:2786–2792CrossRefPubMedGoogle Scholar
  25. 25.
    Johnston JA, Wagner DP, Timmons S, Welsh D, Tsevat J, Render ML (2002) Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients. Med Care 40:929–940CrossRefGoogle Scholar
  26. 26.
    Durairaj L, Will JG, Torner JC, Doebbeling BN (2003) Prognostic factors for mortality following interhospital transfers to the medical intensive care unit of a tertiary referral center. Crit Care Med 31:1981–1986CrossRefGoogle Scholar
  27. 27.
    Needham DM, Bronskill SE, Sibbald WJ, Pronovost PJ, Laupacis A (2004) Mechanical ventilation in Ontario, 1992–2000: incidence, survival, and hospital bed utilization of noncardiac surgery adult patients. Crit Care Med 32:1504–1509CrossRefGoogle Scholar
  28. 28.
    Lee H, Doig CJ, Ghali WA, Donaldson C, Johnson D, Manns B (2004) Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med 32:981–985CrossRefGoogle Scholar
  29. 29.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMedGoogle Scholar
  30. 30.
    Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J (1993) Mortality probability models (MPM II) based on an international cohort of intensive care unit patients. JAMA 270:2478–2486PubMedGoogle Scholar
  31. 31.
    Poses RM, McClish DK, Smith WR, Bekes C, Scott WE (1996) Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol 49:743–747CrossRefGoogle Scholar
  32. 32.
    Paleri V, Wight RG (2002) Applicability of the adult comorbidity evaluation-27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study. J Laryngol Otol 116:200–205CrossRefGoogle Scholar
  33. 33.
    Romano PS, Roos LL, Jollis JG (1993) Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 46:1075–1079CrossRefGoogle Scholar
  34. 34.
    Grossman E, Messerli FH, Boyko V, Goldbourt U (2002) Is there an association between hypertension and cancer mortality? Am J Med 112:479–486CrossRefGoogle Scholar
  35. 35.
    Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850CrossRefPubMedGoogle Scholar
  36. 36.
    Wehler M, Martus P, Geise A, Bost A, Mueller A, Hahn EG, Strauss R (2001) Changes in quality of life after medical intensive care. Intensive Care Med 27:154–159CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Márcio Soares
    • 1
    • 2
  • Jorge I. F. Salluh
    • 1
    • 2
    • 3
  • Carlos Gil Ferreira
    • 4
  • Ronir R. Luiz
    • 5
  • Nelson Spector
    • 2
    • 6
  • José R. Rocco
    • 2
    • 6
  1. 1.Intensive Care Unit, Instituto Nacional de CâncerCentro de Tratamento Intensivo 10° AndarRio de JaneiroBrazil
  2. 2.Faculdade de MedicinaUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil
  3. 3.Intensive Care UnitHospital Barra D’OrRio de JaneiroBrazil
  4. 4.Department of Clinical ResearchInstituto Nacional de CâncerRio de JaneiroBrazil
  5. 5.Núcleo de Estudos de Saúde ColetivaUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil
  6. 6.Hospital Universitário Clementino Fraga FilhoUniversidade Federal do Rio de JaneiroRio de JaneiroBrazil

Personalised recommendations